ASPIRE PHARMA LIMITEDActive
Key figures
ASPIRE PHARMA LIMITED does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.
Ratios
2025Balance sheet structure
Dividends
from the accountsDividends paid in the financial year: £5,800,000 (25% of the profit for the year).
Filed accounts2020–2025
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Turnover | 62,703,489 | 81,729,020 | — | — | — |
| Profit for the year | 11,225,364 | 19,837,187 | 19,533,952 | 23,092,481 | 21,824,000 |
| Cash at bank and in hand | 9,189,523 | 8,838,159 | 9,678,345 | 8,506,998 | 7,034,000 |
| Total assets | 60,690,165 | 65,128,306 | 77,298,147 | 96,364,516 | 123,628,000 |
| Total liabilities | 14,246,917 | 16,911,355 | 27,770,453 | 29,463,201 | 34,450,000 |
| Net assets / total equity | 46,229,764 | 48,216,951 | 48,507,716 | 65,800,197 | 87,624,000 |
| Average number of employees | 63 | 71 | 79 | 100 | 1 |
| Average pay (per year) | 155,120 | 53,871 | 59,257 | 72,625 | 7,976,000 |
| Dividends paid | 3,682,860 | 17,850,000 | 19,243,187 | 5,800,000 | — |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: ASPIRE PHARMA LIMITED
Company
ASPIRE PHARMA LIMITED is a private limited company registered with Companies House under company number 06828501. It was incorporated on 24 Feb 2009. Its status is active. The registered office is in Godalming (GU7). Its nature of business (SIC 2007) is wholesale of pharmaceutical goods (46460).
Accounts
The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files full accounts. Profit for the year was £21,824,000. Net assets were £87,624,000, up 33.2% on the previous year. Cash at bank and in hand was £7,034,000. Total assets were £123,628,000 and total liabilities £34,450,000. The company had an average of 1 employee. Figures are available for 6 financial years (2020–2025).
Control and charges
The company has 3 current directors. One person with significant control is registered. 1 of 4 registered charges are outstanding.
Filing deadlines
The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 5 Sep 2027.